Conformational restrictions in the active site of unliganded human caspase-3

Journal of Molecular Recognition

Volumn 16, Issue 3, 2003, Pages 121-124

  Ni, Chao Zhou ^a   Li, Chenglong ^a,c   Wu, Joe C ^b   Spada, Alfred P ^b   Ely, Kathryn R ^a  

^a BURNHAM INSTITUTE   (United States)

^b PFIZER INC   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Active site; Apoptosis; Caspase 3; Cell death; Crystallography; Cysteine protease

Indexed keywords

APOPTOSIS; BINDING SITES; CASPASE 3; CASPASES; CELL LINE; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; HUMANS; LIGANDS; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEINS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 0038306254     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.615     Document Type: Article

References (25)

1. Barrett AJ, Rawlings ND. 2001. Evolutionary lines of cysteine peptidases. Biol. Chem. 382: 727-733.
2. Blanchard H, Kodandapani L, Mittl PR, Marco SD, Krebs JF, Wu JC, Tomaselli KJ, Grutter MG. 1999. The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis. Struct. Fold Des. 7: 1125-1133.
3. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. 1998. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54: 905-921.
4. Chai J, Shiozaki E, Srinivasula SM, Wu Q, Datta P, Alnemri ES, Shi Y, Dataa P. 2001. Structural basis of caspase-7 inhibition by XIAP. Cell 104: 769-780.
5. Christopher JA. 1998. SPOCK: The Structural Properties Observation and Calculation Kit (Program Manual). Texas A&M University: College Station, TX.
6. Cohen GM. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326(Pt 1): 1-16.
7. Huang Y, Park YC, Rich RL, Segal D, Myszka DG, Wu H. 2001. Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell 104: 781-790.
8. Jones TA, Zou JY, Cowan SW, Kjeldgaard M. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47: 110-119.
9. Koradi R, Billeter M, Wuthrich K. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14: 51-55, 29-32.
10. Mittl PR, Di Marco S, Krebs JF, Bai X, Karanewsky DS, Priestle JP, Tomaselli KJ, Grutter MG. 1997. Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-AspVal-Ala-Asp fluoromethyl ketone. J. Biol. Chem. 272: 6539-6547.
11. Navaza J. 1994. AMoRe, an automated package for molecular replacement. Acta Crystallogr. A A50: 157-163.
12. Nicholson DW. 1999. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Diff. 6: 1028-1042.
13. Nunez G, Benedict MA, Hu Y, Inohara N. 1998. Caspases: the proteases of the apoptotic pathway. Oncogene 17: 3237-3245.
14. Otwinowski Z, Minor W. 1997. Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol. 276: 307-326.
15. Rano TA, Timkey T, Peterson EP, Rotonda J, Nicholson DW, Becker JW, Chapman KT, Thornberry NA. 1997. A combinatorial approach for determining protease specificities: application to interleukin-1beta converting enzyme (ICE). Chem. Biol. 4: 149-155.
16. Renatus M, Stennicke HR, Scott FL, Liddington RC, Salvesen GS. 2001. Dimer formation drives the activation of the cell death protease caspase 9. Proc. Natl Acad. Sci. USA 98: 14250-14255.
17. Riedl SJ, Fuentes-Prior P, Renatus M, Kairies N, Krapp S, Huber R, Salvesen GS, Bode W. 2001a. Structural basis for the activation of human procaspase-7. Proc. Natl Acad. Sci. USA 98: 14790-14795.
18. Riedl SJ, Renatus M, Schwarzenbacher R, Zhou Q, Sun C, Fesik SW, Liddington RC, Salvesen GS. 2001b. Structural basis for the inhibition of caspase-3 by XIAP. Cell 104: 791-800.
19. Rotonda J, Nicholson DW, Fazil KM, Gallant M, Gareau Y, Labelle M, Peterson EP, Rasper DM, Ruel R, Vaillancourt JP, Thornberry NA, Becker JW. 1996. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat. Struct. Biol. 3: 619-625.
20. Salvesen GS, Dixit VM. 1997. Caspases: intracellular signaling by proteolysis. Cell 91: 443-446.
21. Thornberry NA, Lazebnik Y. 1998. Caspases: enemies within. Science 281: 1312-1316.
22. Walker NP, Talanian RV, Brady KD, Dang LC, Bump NJ, Ferenz CR, Franklin S, Ghayur T, Hackett MC, Hammill LD. 1994. Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer. Cell 78: 343-352.
23. Watt W, Koeplinger KA, Mildner AM, Heinrikson RL, Tomasselli AG, Watenpaugh KD. 1999. The atomic-resolution structure of human caspase-8, a key activator of apoptosis. Struct. Fold Des. 7: 1135-1143.
24. Wei Y, Fox T, Chambers SP, Sintchak J, Coll JT, Golec JM, Swenson L, Wilson KP, Charifson PS. 2000. The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. Chem. Biol. 7: 423-432.
25. Xu G, Cirilli M, Huang Y, Rich RL, Myszka DG, Wu H. 2001. Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex. Nature 410: 494-497.